Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: ajtj99 who wrote (58033)	4/27/2022 10:28:27 AM
From: h_	Respond to of 98002

No offense to her, but the inventor of the test stated it's not suitable as a clinical tool to assess infection status. Without a standard number of cycles, the result is virtually meaningless since you can amplify an almost non-existent quantity of anything until you "find it." You can't compare results at 28 cycles with those at 45, but that is what we're given in the form of statistics where cycle rate is completely unaccounted for. I can't remember the jurisdiction, but one admitted that only about 6% were likely actual infections.